Journal Article

PON1 gene polymorphisms in patients with chronic obstructive pulmonary disease

Rumora, Lada, Beriša, Mirela, Rako, Ivana, Popović-Grle, Sanja, Grdić Rajković, Marija, Vukić Dugac, Andrea, Rogić, Dunja, Radić Antolić, Margareta

2018

Overview

AimsChronic obstructive pulmonary disease (COPD) is characterised with oxidative stress. Paraoxonase 1 (PON1) is an enzyme, coded by PON1 gene, with distinctive antiatherogenic and antioxidative roles. We aimed to investigate the frequencies of Q192R, L55M and −108C>T polymorphisms and association of those polymorphisms with paraoxonase and arylesterase activities in patients with COPD.Methods PON1 genotype was determined by PCR–restriction fragment length polymorphism method. PON1 activity was measured by paraoxon and phenylacetate.ResultsOnly −108C>T polymorphism resulted in significantly different distribution of genotypes and alleles, with higher frequency of TT genotype and T allele in patients compared with control subjects. Moreover, T allele (OR 2.29 (95% CI 1.54 to 3.41); p<0.001) as well as TT genotype (OR 5.00 (95% CI 2.19 to 11.43); p<0.001) showed an association with the disease. −108C>T polymorphism was suggested as a significant diagnostic predictor for the disease (OR (95% CI) 2.65 (1.53 to 4.59), p=0.001), with an area under the receiver operating characteristic curve of 0.90 (95% CI 0.84 to 0.93) and with 83.90% of correctly classified cases.ConclusionsHigher frequency of TT genotype and T allele could contribute to the observed reduction of PON1 activity in patients with COPD. T allele and TT genotype are associated with COPD, and the PON1−108C>T polymorphism could be a potential predictor of the disease.

• Publisher: BMJ Publishing Group LTD
• Subject: Atherosclerosis / Biochemistry / Cardiovascular disease / Chronic obstructive pulmonary disease / Deoxyribonucleic acid / DNA / Enzymes / Lung diseases / Mutation / Oxidative stress / Pathogenesis / Physiology / Polymorphism / Smoking